Delivery Order SPE2DB22D1017-SPE2DB25FG4GN
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. The contract is valued at $1,516.78 and carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Methylphenidate 2.5 mg chewable tablets (100 count) with a ceiling value of $7,107.77. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The order is set to reach completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Methylphenidate HCL chewable tablets at 10mg strength. This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,128.45 and is scheduled for completion by December 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of methylphenidate 5 mg chewable tablets (100-count bottles) with a contract ceiling value of $1,734.28. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Methylphenidate 2.5 mg chewable tablets in quantities of 100 units, with a ceiling value of $1,069.37. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a pediatric attention-deficit/hyperactivity disorder medication procurement supporting military and federal healthcare systems. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate 5 mg chewable tablets (100-count units) valued at $3,794.71 with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform fulfillment from its Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.56 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed-price contract. The delivery order was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and is classified as a non-set-aside competitive award. Performance will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.80 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units). This competitive, non-set-aside contract was awarded on September 25, 2025, with completion scheduled for September 26, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4GNDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 5, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. The contract is valued at $2,017.97 and will be completed by June 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling AmerisourceBergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical Supply Chain relies on such contracts to fulfill critical pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with this specific delivery order representing a routine fulfillment of neurological medication requirements within that larger framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/5/25 |